Therefore, these data indicated that the Ki-67 level at the invasive front was related to metastatic cells in malignancies, and that loss of claudin-18 was one of the markers of GC aggressiveness and might be related to the development of metastasis, which necessitates additional surgery after ESD treatment. Here, MKI67 is linked to gastric cancer.